Jürgens G, Graudal N A
Cochrane Database Syst Rev. 2004(1):CD004022. doi: 10.1002/14651858.CD004022.pub2.
One of the controversies in preventive medicine is, whether a general reduction in sodium intake can decrease the blood pressure of a population and thereby reduce cardiovascular mortality and morbidity. In recent years the debate has been extended by studies indicating that reducing sodium intake has effects on the hormone and lipid profile.
To estimate the effects of low sodium versus high sodium intake on systolic and diastolic blood pressure (SBP and DBP), plasma or serum levels of renin, aldosterone, catecholamines, cholesterol and triglycerides.
"MEDLINE" and reference lists of relevant articles were searched from 1966 through December 2001.
Studies randomising persons to low sodium and high sodium diets were included if they evaluated at least one of the above outcome parameters.
Two authors independently extracted the data, which were analysed by means of Review Manager 4.1.
In 57 trials of mainly Caucasians with normal blood pressure, low sodium intake reduced SBP by -1.27 mm Hg (CI: -1.76; -0.77)(p<0.0001) and DBP by -0.54 mm Hg (CI: -0.94; -0.14) (p = 0.009) as compared to high sodium intake. In 58 trials of mainly Caucasians with elevated blood pressure, low sodium intake reduced SBP by -4.18 mm Hg (CI: -5.08; - 3.27) (p < 0.0001) and DBP by -1.98 mm Hg (CI: -2.46; -1.32) (p < 0.0001) as compared to high sodium intake. The median duration of the intervention was 8 days in the normal blood pressure trials (range 4-1100) and 28 days in the elevated blood pressure trials (range 4-365). Multiple regression analyses showed no independent effect of duration on the effect size. In 8 trials of blacks with normal or elevated blood pressure, low sodium intake reduced SBP by -6.44 mm Hg (CI: -9.13; -3.74) (p < 0.0001) and DBP by -1.98 mm Hg (CI: -4.75; 0.78) (p = 0.16) as compared to high sodium intake. The magnitude of blood pressure reduction was also greater in a single trial in Japanese patients. There was also a significant increase in plasma or serum renin, 304% (p < 0.0001), aldosterone, 322%, (p < 0.0001), noradrenaline, 30% (p < 0.0001), cholesterol, 5.4% (p < 0.0001) and LDL cholesterol, 4.6% (p < 0.004), and a borderline increase in adrenaline, 12% (p = 0.04) and triglyceride, 5.9% (p = 0.03) with low sodium intake as compared with high sodium intake.
REVIEWER'S CONCLUSIONS: The magnitude of the effect in Caucasians with normal blood pressure does not warrant a general recommendation to reduce sodium intake. Reduced sodium intake in Caucasians with elevated blood pressure has a useful effect to reduce blood pressure in the short-term. The results suggest that the effect of low versus high sodium intake on blood pressure was greater in Black and Asian patients than in Caucasians. However, the number of studies in black (8) and Asian patients (1) was insufficient for different recommendations. Additional long-term trials of the effect of reduced dietary sodium intake on blood pressure, metabolic variables, morbidity and mortality are required to establish whether this is a useful prophylactic or treatment strategy.
预防医学中的争议之一是,钠摄入量的普遍降低是否能降低人群血压,从而降低心血管疾病的死亡率和发病率。近年来,一些研究表明减少钠摄入量会对激素和血脂水平产生影响,这使得该争论进一步扩大。
评估低钠摄入与高钠摄入对收缩压和舒张压(SBP和DBP)、血浆或血清肾素、醛固酮、儿茶酚胺、胆固醇和甘油三酯水平的影响。
检索了1966年至2001年12月的“医学索引在线数据库(MEDLINE)”及相关文章的参考文献列表。
将人群随机分为低钠饮食和高钠饮食的研究,若评估了上述至少一项结局参数,则纳入研究。
两位作者独立提取数据,采用Review Manager 4.1软件进行分析。
在57项主要针对血压正常的白种人的试验中,与高钠摄入相比,低钠摄入使收缩压降低了-1.27 mmHg(95%置信区间:-1.76;-0.77)(p<0.0001),舒张压降低了-0.54 mmHg(95%置信区间:-0.94;-0.14)(p = 0.009)。在58项主要针对血压升高的白种人的试验中,与高钠摄入相比,低钠摄入使收缩压降低了-4.18 mmHg(95%置信区间:-5.08;-3.27)(p < 0.0001),舒张压降低了-1.98 mmHg(95%置信区间:-2.46;-1.32)(p < 0.0001)。血压正常试验的干预中位持续时间为8天(范围4 - 1100天),血压升高试验的干预中位持续时间为28天(范围4 - 365天)。多元回归分析显示,干预持续时间对效应大小无独立影响。在8项针对血压正常或升高的黑人的试验中,与高钠摄入相比,低钠摄入使收缩压降低了-6.44 mmHg(95%置信区间:-9.13;-3.74)(p < 0.0001),舒张压降低了-1.98 mmHg(95%置信区间:-4.75;0.78)(p = 0.16)。在一项针对日本患者的试验中,血压降低幅度也更大。与高钠摄入相比,低钠摄入还使血浆或血清肾素显著升高304%(p < 0.0001)、醛固酮升高322%(p < 0.0001)、去甲肾上腺素升高30%(p < 0.0001)、胆固醇升高5.4%(p < 0.0001)以及低密度脂蛋白胆固醇升高4.6%(p < 0.004),肾上腺素升高12%(p = 0.04)和甘油三酯升高5.9%(p = 0.03)接近显著升高。
血压正常的白种人钠摄入量降低的效果并不足以支持普遍推荐减少钠摄入。血压升高的白种人减少钠摄入在短期内对降低血压有有益作用。结果表明,低钠摄入与高钠摄入相比,对血压的影响在黑人和亚洲患者中比在白种人中更大。然而,针对黑人(8项)和亚洲患者(1项)的研究数量不足以做出不同的推荐。需要进行更多关于减少饮食中钠摄入量对血压、代谢变量、发病率和死亡率影响的长期试验,以确定这是否是一种有效的预防或治疗策略。